Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Publication list

publication_uri type publication_title year doi pmid journal_uri
http://vivo.scripps.edu/individual/e2n87764 AcademicArticle Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK inhibitors 2012 10.1038/leu.2012.96 22469781 http://vivo.scripps.edu/individual/endnote45694

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support